Pace University PA students raised $13,600 for leukemia and lymphoma research during the annual Light the Night Walk October 1.
For their efforts, Pace PA students were recognized as members of the “10 Grand Club” along with Macy’s, Ralph Lauren, BNY Mellon and Credit Suisse – even exceeding corporate teams such as US Bank, Fidelity Cares and Aerotek.
PA student and event organizer, J.P. Bitagna, spoke to his fellow classmates about how this event is an important landmark in the midst of didactic year saying, “The growing PA profession requires minds that understand the science of the body, attitudes that look to elevate the PA profession, and personalities that bring sincerity to every patient. We are students, but that isn’t stopping us from giving our all to help the community. We are students, and we are quickly cementing ourselves as supporters and advocates for patients.”
Students described this event and fundraising accomplishment as both humbling and motivating. Bitagna said much of fundraising was done through social media.
“As a class, we all made a conscious effort to post once a week to remind our friends about the event,” Bitagna said. “We are also extremely lucky that our professors donated as well, further showcasing the supportive nature of the PA community.”
The team of 50 students walked along the Hudson River in Manhattan along with other survivors, fighters, and their families. Onestudent described her evening at the Light the Night Walk as an uplifting experience. “Even though it was a cold, rainy evening, there was an overwhelming feeling of hope among participants – we were marching for a purpose with our lanterns held high. Our class was happy to be there knowing that we are walking in support of a brighter future for those affected by blood cancers.”
The annual event, hosted by the Leukemia and Lymphoma Society, raises awareness and funds for blood cancer research. Funds will go to advance breakthrough therapies for blood cancer patients including gene-targeted therapies, immunotherapy, and to help bridge the gap between academic discovery and pharmaceutical development. The goal of the Leukemia and Lymphoma Society is to ultimately cure leukemia, lymphoma, Hodgkin’s disease, and myeloma, and to improve the quality of life for patients and their families.
The class of 2017 was thankful for all of their friends, family and staff for supporting us in this endeavor. Observing how students, faculty and staff came together to support this cause further reinforced they chose the right profession and the right program to be a part of.